| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Journal of Lipid Research, Vol 35, 1297-1310, Copyright © 1994 by Lipid Research, Inc.
ARTICLES |
HV de Silva, J Mas-Oliva, JM Taylor and RW Mahley
Gladstone Institute of Cardiovascular Disease, Departments of Physiology, University of California, San Francisco 94141-9100.
Plasma lipoprotein fractions from inbred C57BL/6J mice and outbred ICR mice were prepared by sequential density ultracentrifugation using density ranges that were optimized for separating mouse lipoproteins, or by Superose 6 HR10/30 fast performance liquid chromatography (FPLC). The lipoproteins were characterized by migration behavior in agarose, apolipoprotein (apo) composition, lipid composition, and particle size distribution. Both sequential density ultracentrifugation and Superose 6 FPLC were adapted for the separation of lipoproteins from a single mouse. In the plasma of ICR and C57BL/6J mice, in contrast to human plasma, alpha-migrating high density lipoproteins (HDL) and beta- migrating low density lipoproteins (LDL) had overlapping density ranges. For example, beta-migrating apoB-100 LDL, slow pre-beta- migrating apoB-48 remnants, and alpha-migrating HDL1 were found together in the d 1.02-1.04 g/ml fraction. The d 1.04-1.06 g/ml fraction contained beta-migrating apoB-100 LDL and alpha-migrating HDL1. Large HDL1 that were found at d 1.02-1.06 g/ml were apoE-rich HDL1, characteristic of cholesteryl ester transfer protein-deficient mammals. The d 1.10-1.21 g/ml fraction, in addition to alpha-migrating HDL, included unique slow beta-migrating particles that contained apoE and apoA-I but was deficient in neutral lipids. These slow beta-HDL eluted in the same FPLC fractions as dense alpha-migrating HDL. Compared to ICR mouse plasma, C57BL/6J mouse plasma contained more LDL and less HDL1, which might contribute to the susceptibility of C57BL/6J and the resistance of ICR mice to the development of aortic fatty streak lesions when challenged with an atherogenic diet.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  B. J. McMillan and C. A. Bradfield The Aryl hydrocarbon receptor is activated by modified low-density lipoprotein PNAS, January 23, 2007; 104(4): 1412 - 1417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Joyce, E. M. Wagner, F. Basso, M. J. Amar, L. A. Freeman, R. D. Shamburek, C. L. Knapper, J. Syed, J. Wu, B. L. Vaisman, et al. ABCA1 Overexpression in the Liver of LDLr-KO Mice Leads to Accumulation of Pro-atherogenic Lipoproteins and Enhanced Atherosclerosis J. Biol. Chem., November 3, 2006; 281(44): 33053 - 33065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kodvawala, A. B. Ghering, W. S. Davidson, and D. Y. Hui Carboxyl Ester Lipase Expression in Macrophages Increases Cholesteryl Ester Accumulation and Promotes Atherosclerosis J. Biol. Chem., November 18, 2005; 280(46): 38592 - 38598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Yao and L. A. Woollett Adult sterol metabolism is not affected by a positive sterol balance in the neonatal Golden Syrian hamster Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2005; 288(3): R561 - R566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Mann, F. E. Thorngate, Y. Katoh-Fukui, H. Hamanaka, D. L. Williams, S. Fujita, and B. T. Lamb Independent effects of APOE on cholesterol metabolism and brain A{beta} levels in an Alzheimer disease mouse model Hum. Mol. Genet., September 1, 2004; 13(17): 1959 - 1968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-C. Jiang, T. P. Beyer, Z. Li, J. Liu, W. Quan, R. J. Schmidt, Y. Zhang, W. R. Bensch, P. I. Eacho, and G. Cao Enlargement of High Density Lipoprotein in Mice via Liver X Receptor Activation Requires Apolipoprotein E and Is Abolished by Cholesteryl Ester Transfer Protein Expression J. Biol. Chem., December 5, 2003; 278(49): 49072 - 49078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. McConihay, A. M. Honkomp, N. A. Granholm, and L. A. Woollett Maternal high density lipoproteins affect fetal mass and extra-embryonic fetal tissue sterol metabolism in the mouse J. Lipid Res., March 1, 2000; 41(3): 424 - 432. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Huang, Z.-S. Ji, W. J. Brecht, S. C. Rall Jr, J. M. Taylor, and R. W. Mahley Overexpression of Apolipoprotein E3 in Transgenic Rabbits Causes Combined Hyperlipidemia by Stimulating Hepatic VLDL Production and Impairing VLDL Lipolysis Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 2952 - 2959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Caligiuri, B. Levy, J. Pernow, P. Thoren, and G. K. Hansson Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice PNAS, June 8, 1999; 96(12): 6920 - 6924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. G. Lamping, D. W. Nuno, D. A. Chappell, and F. M. Faraci Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1999; 276(4): R1023 - R1029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Paka, Y. Kako, J. C. Obunike, and S. Pillarisetti Apolipoprotein E Containing High Density Lipoprotein Stimulates Endothelial Production of Heparan Sulfate Rich in Biologically Active Heparin-like Domains. A POTENTIAL MECHANISM FOR THE ANTI-ATHEROGENIC ACTIONS OF VASCULAR APOLIPOPROTEIN E J. Biol. Chem., February 19, 1999; 274(8): 4816 - 4823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Huang, X. Q. Liu, S. C. Rall Jr., J. M. Taylor, A. von Eckardstein, G. Assmann, and R. W. Mahley Overexpression and Accumulation of Apolipoprotein E as a Cause of Hypertriglyceridemia J. Biol. Chem., October 9, 1998; 273(41): 26388 - 26393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Huang, X. Q. Liu, S. C. Rall Jr., and R. W. Mahley Apolipoprotein E2 Reduces the Low Density Lipoprotein Level in Transgenic Mice by Impairing Lipoprotein Lipase-mediated Lipolysis of Triglyceride-rich Lipoproteins J. Biol. Chem., July 10, 1998; 273(28): 17483 - 17490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Turley, D. K. Burns, and J. M. Dietschy Preferential utilization of newly synthesized cholesterol for brain growth in neonatal lambs Am J Physiol Endocrinol Metab, June 1, 1998; 274(6): E1099 - E1105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Spady, J. A. Cuthbert, M. N. Willard, and R. S. Meidell Overexpression of Cholesterol 7alpha -Hydroxylase (CYP7A) in Mice Lacking the Low Density Lipoprotein (LDL) Receptor Gene. LDL TRANSPORT AND PLASMA LDL CONCENTRATIONS ARE REDUCED J. Biol. Chem., January 2, 1998; 273(1): 126 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rigotti, B. L. Trigatti, M. Penman, H. Rayburn, J. Herz, and M. Krieger A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism PNAS, November 11, 1997; 94(23): 12610 - 12615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bonthu, D. D. Heistad, D. A. Chappell, K. G. Lamping, and F. M. Faraci Atherosclerosis, Vascular Remodeling, and Impairment of Endothelium-Dependent Relaxation in Genetically Altered Hyperlipidemic Mice Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2333 - 2340. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Huang, S. C. Rall Jr, and R. W. Mahley Genetic Factors Precipitating Type III Hyperlipoproteinemia in Hypolipidemic Transgenic Mice Expressing Human Apolipoprotein E2 Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2817 - 2824. [Abstract] [Full Text]
|
|
|
|
|
|
P. M. Sullivan, H. Mezdour, Y. Aratani, C. Knouff, J. Najib, R. L. Reddick, S. H. Quarfordt, and N. Maeda Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis J. Biol. Chem., July 18, 1997; 272(29): 17972 - 17980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Mezdour, R. Jones, C. Dengremont, G. Castro, and N. Maeda Hepatic Lipase Deficiency Increases Plasma Cholesterol but Reduces Susceptibility to Atherosclerosis in Apolipoprotein E-deficient Mice J. Biol. Chem., May 23, 1997; 272(21): 13570 - 13575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Huang, S. W. Schwendner, S. C. Rall Jr., and R. W. Mahley Hypolipidemic and Hyperlipidemic Phenotypes in Transgenic Mice Expressing Human Apolipoprotein E2 J. Biol. Chem., November 15, 1996; 271(46): 29146 - 29151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nakamuta, B. H.-J. Chang, E. Zsigmond, K. Kobayashi, H. Lei, B. Y. Ishida, K. Oka, E. Li, and L. Chan Complete Phenotypic Characterization of apobec-1 Knockout Mice with a Wild-type Genetic Background and a Human Apolipoprotein B Transgenic Background, and Restoration of Apolipoprotein B mRNA Editing by Somatic Gene Transfer of Apobec-1 J. Biol. Chem., October 18, 1996; 271(42): 25981 - 25988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Vaisman, H.-G. Klein, M. Rouis, A. M. Bérard, M. R. Kindt, G. D. Talley, S. M. Meyn, R. F. HoytJr., S. M. Marcovina, J. J. Albers, et al. Overexpression of Human Lecithin Cholesterol Acyltransferase Leads to Hyperalphalipoproteinemia in Transgenic Mice J. Biol. Chem., May 19, 1995; 270(20): 12269 - 12275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Stevenson, J. Marshall-Neff, B. Teng, C. B. Lee, S. Roy, and A. McClelland Phenotypic Correction of Hypercholesterolemia in ApoE-Deficient Mice by Adenovirus-Mediated In Vivo Gene Transfer Arterioscler. Thromb. Vasc. Biol., April 1, 1995; 15(4): 479 - 484. [Abstract] [Full Text]
|
|
|
|
|
|
G. E. Homanics, H. V. de Silva, J.ús Osada, S. H. Zhang, H. Wong, J. Borensztajn, and N. Maeda Mild Dyslipidemia in Mice following Targeted Inactivation of the Hepatic Lipase Gene J. Biol. Chem., February 17, 1995; 270(7): 2974 - 2980. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
